A. Moreno

发表

Low risk of bacterial co-infection, opportunistic diseases, and persistent immunosuppression in people living with HIV and COVID-19

M. Pérez-Elías, J. Casado, P. Vizcarra, 2022, Infection.

Risk factors for development of tuberculosis after isoniazid chemoprophylaxis in human immunodeficiency virus-infected patients.

C. Quereda, E. Navas, S. Moreno, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Higher Virological Effectiveness of NNRTI-Based Antiretroviral Regimens Containing Nevirapine or Efavirenz Compared to a Triple NRTI Regimen As Initial Therapy in HIV-1-Infected Adults

V. Abraira, C. Quereda, E. Navas, 2005, HIV clinical trials.

Severe sirolimus-related inflammatory state anemia in an HIV+ liver transplant patient with calcineurin inhibitor renal insufficiency: a case report.

C. Quereda, J. Fortún, J. Casado, 2008, Transplantation proceedings.

Treatment of Chronic Hepatitis C in “ Difficult-to-Treat” Patients in the Clinical Setting

C. Quereda, A. Moreno, R. Bárcena, 2008 .

Individualizing salvage regimens: the inhibitory quotient (Ctrough/IC50) as predictor of virological response.

S. Moreno, M. Pérez-Elías, A. Antela, 2003, AIDS.

Extent and importance of cross-resistance to efavirenz after nevirapine failure.

K. Hertogs, S. Moreno, J. Casado, 2002, AIDS research and human retroviruses.

Safety and anti-HCV effect of prolonged intravenous silibinin in HCV genotype 1 subjects in the immediate liver transplant period.

A. Albillos, M. Rodríguez-Gandía, A. Moreno, 2013, Journal of hepatology.

Is Liver Transplantation Advisable for Isoniazid Fulminant Hepatitis in Active Extrapulmonary Tuberculosis?

J. Fortún, A. Moreno, R. Bárcena, 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort

R. López-Vélez, P. Martín-Dávila, S. Chamorro, 2020, The Lancet HIV.

Switching to abacavir versus use of a nucleoside‐sparing dual regimen for HIV‐infected patients with tenofovir‐associated renal toxicity

S. Moreno, A. Moreno, C. Santiuste, 2018, HIV medicine.

The Magnitude of Week 4 HCV RNA Decay on Pegylated Interferon/Ribavirin Accurately Predicts Virological Failure in Patients with Genotype 1

A. Muriel, C. Quereda, Miguel García, 2006, Antiviral therapy.

Severe rhabdomyolysis due to rosuvastatin in a liver transplant subject with human immunodeficiency virus and immunosuppressive therapy–related dyslipidemia

C. Quereda, M. Rodríguez-Gandía, M. Pérez-Elías, 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Safety and Pharmacokinetics of Lopinavir in HIV/HCV Coinfected Patients with Advanced Liver Disease

S. Moreno, M. Pérez-Elías, J. Casado, 2011, HIV clinical trials.

The role of liver biopsy in the management of chronic hepatitis C in patients infected with the human immunodeficiency virus.

C. Quereda, E. Navas, S. Moreno, 2004, Human pathology.

Pegylated interferon α2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients

C. Quereda, S. Moreno, M. Pérez-Elías, 2003, AIDS.

All‐oral direct‐acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV–coinfected subjects in real‐world practice: Madrid coinfection registry findings

J. Losa, P. Ryan, C. Barros, 2018, Hepatology.

Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus

J. Macías, J. Pineda, A. Rivero, 2009, Hepatology.

Interferon alpha for the treatment of chronic hepatitis C in patients infected with human immunodeficiency virus. Hepatitis-HIV Spanish Study Group.

J. Castilla, J. del Romero, J. González-lahoz, 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Raltegravir pharmacokinetics in HIV/HCV-coinfected patients with advanced liver cirrhosis (Child-Pugh C).

C. Quereda, J. Moltó, N. Madrid-Elena, 2014, The Journal of antimicrobial chemotherapy.

Safe use of pegylated interferon/ribavirin in hepatitis C virus cirrhotic patients with hypersplenism after partial splenic embolization

A. Muriel, C. Quereda, S. Moreno, 2005, European journal of gastroenterology & hepatology.

Virological response to short-course maraviroc monotherapy does not predict viral tropism in HIV-1-infected treatment-naive patients.

J. Zamora, J. Pérez-Molina, N. Madrid-Elena, 2014, The Journal of antimicrobial chemotherapy.

Increased Risk of Serious Non-AIDS-Related Events in HIV-Infected Subjects on Antiretroviral Therapy Associated with a Low CD4/CD8 Ratio

A. Royuela, C. Quereda, J. Pérez-Molina, 2014, PloS one.

Delayed liver fibrosis in HTLV-2-infected patients co-infected with HIV-1 and hepatitis C virus with suppressive antiretroviral therapy

C. Quereda, S. Moreno, M. Pérez-Elías, 2015, AIDS.

Hepatic steatosis and steatohepatitis in human immunodeficiency virus/hepatitis C virus–coinfected patients

J. Macías, J. Pineda, A. Rivero, 2012, Hepatology.

IFN‐γ+ cell response and IFN‐γ release concordance after in vitro SARS‐CoV‐2 stimulation

C. Quereda, J. Casado, P. Vizcarra, 2021, European journal of clinical investigation.

Relevant Gender Differences in Epidemiological Profile, Exposure to First Antiretroviral Regimen and Survival in the Spanish Aids Research Network Cohort

A. Muriel, J. del Romero, J. Blanco, 2014, Antiviral therapy.

Prevalence of Primary Resistance Mutations to Integrase Inhibitors in Treatment-Naïve and -Experienced Patients Infected With B and Non-B HIV-1 Variants

Á. Holguín, B. Hernández-Novoa, S. Moreno, 2013 .

Safe co-administration of raltegravir, pegylated-interferon and, ribavirin in HIV individuals with hepatitis C virus-related liver damage.

C. Quereda, S. Moreno, M. Pérez-Elías, 2010, AIDS.

Raltegravir‐based highly active antiretroviral therapy has beneficial effects on the renal function of human immunodeficiency virus–infected patients after solid organ transplantation

C. Quereda, Ó. Pastor, S. Moreno, 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Successful pregnancy after orthotopic liver transplantation in a patient with HIV infection.

C. Quereda, A. Moreno, R. Bárcena, 2005, The New England journal of medicine.

Efficacy and pharmacokinetics of the combination of etravirine plus raltegravir as novel dual antiretroviral maintenance regimen in HIV-infected patients.

S. Moreno, J. Casado, A. Moreno, 2015, Antiviral Research.

Short-Term Effect of Ritonavir-Boosted Atazanavir in Hepatitis B and/or C Co-infected, Treatment-Experienced HIV Patients

B. Clotet, J. Gatell, J. Pérez-Molina, 2009, HIV clinical trials.

Lipid and Apoprotein Profile in HIV-1-Infected Patients After CD4-Guided Treatment Interruption

M. Muñoz-Fernández, J. Arribas, S. Moreno, 2008, Journal of acquired immune deficiency syndromes.

Unravelling hip–spine bone mineral density discordance in people living with HIV

J. Casado, P. Vizcarra, M. Vivancos, 2022, Journal of Bone and Mineral Metabolism.

Vascular disease in HIV-infected patients: a comparative study of two different therapeutic periods (1994-1997 versus 1998-2000).

S. Moreno, M. Pérez-Elías, A. Antela, 2002, AIDS.

SARS-CoV-2 cellular immune response in uninfected health care workers with prolonged and close exposure to COVID-19 patients

C. Quereda, J. Casado, P. Vizcarra, 2020 .

Discovering HIV related information by means of association rules and machine learning

Miguel Ángel Martínez, Juan Martínez-Romo, Lourdes Araujo, 2022, Scientific Reports.

Fibrosis Regression Explains Differences in Outcome in HIV-/HCV-Coinfected Patients with Cirrhosis After Sustained Virological Response

M. Esteban, C. Quereda, S. Moreno, 2015, Digestive Diseases and Sciences.

Partial splenic embolization and peg‐IFN plus RBV in liver transplanted patients with hepatitis C recurrence: safety, efficacy and long‐term outcome

J. Fortún, A. Moreno, J. Graus, 2009, Clinical transplantation.

Partial Splenic Embolization for the Treatment of Hypersplenism in Cirrhotic HIV/HCV Patients Prior to Pegylated Interferon and Ribavirin

C. Quereda, S. Moreno, M. Pérez-Elías, 2004, Antiviral therapy.

Weight gain in people living with HIV switched to dual therapy: changes in body fat mass.

M. Pérez-Elías, J. Casado, P. Vizcarra, 2019, AIDS.

Viral kinetics and early prediction of nonresponse to peg‐IFN‐α‐2b plus ribavirin in HCV genotypes 1/4 according to HIV serostatus *

C. Quereda, M. Pérez-Elías, A. Antela, 2006, Journal of viral hepatitis.

Dynamics of creatinine estimated glomerular filtration rate using one or more antiretrovirals that inhibit creatinine tubular secretion.

E. Negredo, E. Martinez, J. De La Torre, 2021, The Journal of antimicrobial chemotherapy.

High Rate of Didanosine-Related Mitochondrial Toxicity in HIV/HCV-Coinfected Patients Receiving Ribavirin

A. Muriel, C. Quereda, E. Navas, 2004, Antiviral therapy.

The use of atazanavir in HIV-infected patients with liver cirrhosis: lack of hepatotoxicity and no significant changes in bilirubin values or model for end-stage liver disease score

C. Quereda, B. Hernández-Novoa, S. Moreno, 2011, AIDS.

The influence of patient beliefs and treatment satisfaction on the discontinuation of current first‐line antiretroviral regimens

S. Moreno, A. Moreno, J. Casado, 2016, HIV medicine.

Improving Recognition of Fracture Risk in People with Human Immunodeficiency Virus: Performance and Model Contribution of Two Common Risk Assessment Tools.

J. Casado, P. Vizcarra, M. Vivancos, 2022, AIDS Patients Care and STDs.

Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection

V. de Lédinghen, V. Soriano, G. Satta, 2009, Journal of viral hepatitis.

Interferon α for the Treatment of Chronic Hepatitis C in Patients Infected with Human Immunodeficiency Virus

J. Castilla, V. Soriano, J. González-lahoz, 1996 .

Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection.

C. Quereda, S. Moreno, M. Pérez-Elías, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Clinical features of adrenal insufficiency in patients with acquired immunodeficiency syndrome

M. Pérez-Elías, J. Casado, A. Moreno, 1996, Clinical endocrinology.

Benefit of pegylated interferon-alpha-2a/ribavirin in a patient with common variable immunodeficiency and hepatitis C virus cirrhosis after liver transplantation and splenic embolization.

A. Moreno, J. Blázquez, A. Moreno, 2006, Transplantation.

CD4 cell recovery during successful antiretroviral therapy in naive HIV-infected patients: the role of intravenous drug use

J. Zamora, A. Muriel, C. Quereda, 2004, AIDS.

Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C. The Hepatitis/HIV Spanish Study Group.

J. Castilla, V. Soriano, A. Moreno, 1997, The American journal of gastroenterology.

Effectiveness and Pitfalls of Initial Highly Active Antiretroviral Therapy in HIV-Infected Patients in Routine Clinical Practice

C. Quereda, E. Navas, M. Pérez-Elías, 1999, Antiviral therapy.

Improved graft function in liver‐transplanted patients after partial splenic embolization: reversal of splenic artery steal syndrome?

M. Rodríguez-Gandía, J. Fortún, A. Moreno, 2006, Clinical transplantation.

Syncytial giant cell hepatitis in human immunodeficiency virus-infected patients with chronic hepatitis C: 2 cases and review of the literature.

R. Fernández-Muñoz, C. Quereda, S. Moreno, 2006, Human pathology.

Patients infected with HIV are at high‐risk for hepatitis E virus infection in Spain

J. Galán, A. Moreno, M. Pérez-Gracia, 2014, Journal of medical virology.

[The treatment of chronic hepatitis C with interferon in patients infected with the human immunodeficiency virus. The Spanish Group for the Study of Viral Hepatitis in HIV+ Patients].

J. Castilla, J. del Romero, J. González-lahoz, 1996, Medicina clinica.

Tuberculosis complicating hepatitis C treatment in HIV-infected patients.

A. Muriel, P. Martín-Dávila, C. Quereda, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Long-term outcomes among antiretroviral-naive human immunodeficiency virus-infected patients with small increases in CD4+ cell counts after successful virologic suppression.

S. Moreno, M. Pérez-Elías, A. Antela, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Intramedullary Cysticercosis Cured With Drug Treatment: A Case Report

R. López-Vélez, A. Guerrero, C. Quereda, 1996, Spine.

Safe use of raltegravir and sirolimus in an HIV-infected patient with renal impairment after orthotopic liver transplantation.

C. Quereda, S. Moreno, M. Pérez-Elías, 2008, AIDS.

International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK

Raúl Tabarés Gutiérrez, Samit R. Joshi, H. Jessen, 2016, Journal of the International AIDS Society.

Risk, Diagnostic and Predictor Factors for Classical Hodgkin Lymphoma in HIV-1-Infected Individuals: Role of Plasma Exosome-Derived miR-20a and miR-21

M. Leal, Y. Pacheco, C. Quereda, 2020, Journal of clinical medicine.

Immunological predictors of CD4+ T cell decline in antiretroviral treatment interruptions

M. Muñoz-Fernandez, J. Arribas, S. Moreno, 2008, BMC infectious diseases.

HTLV-2 Enhances CD8+ T Cell-Mediated HIV-1 Inhibition and Reduces HIV-1 Integrated Proviral Load in People Living with HIV-1

C. Quereda, M. Pérez-Elías, J. Casado, 2022, Viruses.

Decrease in serial prevalence of coinfection with hepatitis C virus among HIV-infected patients in Spain, 1997-2006.

F. Vidal, J. Pineda, S. Moreno, 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cerebrovascular Ischemic Events in HIV-1-Infected Patients Receiving Highly Active Antiretroviral Therapy: Incidence and Risk Factors

J. Masjuán, A. Muriel, C. Quereda, 2009, Cerebrovascular Diseases.

HIV Coinfection Predicts Failure of Ledipasvir/Sofosbuvir in Treatment-Naïve Noncirrhotic Patients With HCV Genotype 1

J. Losa, J. Calleja, C. Fernández-Rodríguez, 2019, Open forum infectious diseases.

Direct‐acting antivirals are effective and safe in HCV/HIV‐coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study

J. Miro, V. Cuervas-Mons, M. Londoño, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Brief Report: Reduced Cell-Associated HTLV-2 DNA in Antiretroviral Treated HIV-1–HCV-Coinfected Patients Who Either Received Interferon-&agr;/Ribavirin-Based Hepatitis C Therapy or Had Spontaneous HCV RNA Clearance

C. Quereda, S. Moreno, M. Pérez-Elías, 2015, Journal of acquired immune deficiency syndromes.

International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK

Samit R. Joshi, Charlene A Flash, Thomas Lengauer, 2014 .

Factors associated with the number of drugs in darunavir/cobicistat regimens.

E. Negredo, E. Ribera, M. Pérez-Elías, 2019, The Journal of antimicrobial chemotherapy.

Prevalence of insulin resistance and risk of diabetes mellitus in HIV-infected patients receiving current antiretroviral drugs.

M. Pérez-Elías, J. Casado, A. Moreno, 2014, European journal of endocrinology.

Oxidative Stress Predicts All-Cause Mortality in HIV-Infected Patients

S. Moreno, C. Rodríguez, J. Oteo, 2016, PloS one.

The significance of antiretroviral-associated acute kidney injury in a cohort of ambulatory human immunodeficiency virus-infected patients.

S. Moreno, J. Casado, A. Moreno, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The signi fi cance of antiretroviral-associated acute kidney injury in a cohort of ambulatory human immunode fi ciency virus-infected patients

S. Moreno, J. Casado, A. Moreno, 2013 .

Neutropenia during therapy with peginterferon and ribavirin in HIV-infected subjects with chronic hepatitis C and the risk of infections.

A. Royuela, C. Quereda, E. Navas, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Phenotypic testing predicts virological response in successive protease inhibitor-based regimens

R. Lanier, S. Moreno, M. Pérez-Elías, 2000, AIDS.

Differences in Durability of Treatment with Initial PI-Based Regimens

C. Quereda, E. Navas, S. Moreno, 2003, HIV clinical trials.

Drug resistance in patients experiencing early virological failure under a triple combination including indinavir

V. Soriano, M. Leal, J. Arribas, 2001, AIDS.

Plasma drug levels, genotypic resistance, and virological response to a nelfinavir plus saquinavir-containing regimen

K. Hertogs, S. Moreno, M. Pérez-Elías, 2002, AIDS.

Efficacy and safety of etravirine-containing regimens in a large cohort of HIV/HCV coinfected patients according to liver fibrosis

S. Moreno, M. Pérez-Elías, A. Moreno, 2014, Journal of the International AIDS Society.

Frailty and physical function in older HIV-infected adults

S. Moreno, M. Pérez-Elías, A. Moreno, 2017, Age and ageing.

Immune deficiency is a risk factor for severe COVID‐19 in people living with HIV

D. Cattaneo, C. Spinner, C. Hoffmann, 2020, HIV medicine.

Impact of a structured HIV testing program in a hospital emergency department and a primary care center

A. Muriel, C. Quereda, E. Navas, 2019, PloS one.

Lamivudine plus darunavir boosted with ritonavir as simplification dual regimen in HIV-infected patients

S. Moreno, M. Pérez-Elías, A. Moreno, 2014, Journal of the International AIDS Society.

Intensification of Antiretroviral Therapy with a CCR5 Antagonist in Patients with Chronic HIV-1 Infection: Effect on T Cells Latently Infected

J. Zamora, M. Muñoz-Fernández, E. Muñoz, 2011, PloS one.

Observational Study to Evaluate Clinical Outcomes After First-Line Efavirenz-or Lopinavir-Ritonavir-Based HAART in Treatment-Naive Patients

C. Quereda, E. Navas, S. Moreno, 2009, Journal of the International Association of Physicians in AIDS Care.

Treatment of severe recurrent hepatitis C after liver transplantation in HIV infected patients using sofosbuvir‐based therapy

N. Terrault, G. Guaraldi, J. McHutchison, 2016, Alimentary pharmacology & therapeutics.

Development and Validation of an HIV Risk Exposure and Indicator Conditions Questionnaire to Support Targeted HIV Screening

A. Muriel, C. Quereda, S. Moreno, 2016, Medicine.

Prevalence of primary resistance mutations to integrase inhibitors in treatment-naïve and -experienced patients infected with B and non-B HIV-1 variants.

Á. Holguín, B. Hernández-Novoa, S. Moreno, 2013, HIV clinical trials.

Phenotype or Virtual Phenotype for Choosing Antiretroviral Therapy after Failure: A Prospective, Randomized Study

Ana Moreno, José Sanz, Víctor Abraira, 2002, Antiviral therapy.

COVID-19 and geographical area of origin

R. López-Vélez, P. Martín-Dávila, C. Crespillo-Andújar, 2020, Clinical Microbiology and Infection.

HCV clearance and treatment outcome in genotype 1 HCV-monoinfected, HIV-coinfected and liver transplanted patients on peg-IFN-alpha-2b/ribavirin.

A. Muriel, P. Martín-Dávila, C. Quereda, 2005, Journal of hepatology.

Liver transplantation in HIV‐infected recipients

P. Martín-Dávila, C. Quereda, Miguel García, 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Efficacy of dual therapy with lamivudine plus darunavir boosted with ritonavir once daily in HIV-infected patients with nucleoside analogue toxicity.

S. Moreno, M. Pérez-Elías, J. Casado, 2015, The Journal of antimicrobial chemotherapy.

Liver toxicity and risk of discontinuation in HIV/hepatitis C virus‐coinfected patients receiving an etravirine‐containing antiretroviral regimen: influence of liver fibrosis

C. Quereda, S. Moreno, A. Moreno, 2016, HIV medicine.

Etravirine-based antiretroviral therapy in HIV/hepatitis C virus coinfected advanced fibrosis patients receiving triple therapy against hepatitis C virus with telaprevir.

C. Quereda, M. Pérez-Elías, C. Barros, 2014, AIDS.

Safe coadministration of raltegravir-based HAART in HIV-infected patients with HCV-cirrhosis receiving triple therapy with telaprevir or boceprevir.

C. Quereda, S. Moreno, M. Pérez-Elías, 2012, Journal of acquired immune deficiency syndromes.

Long-term improvement in renal, bone, lipid parameters, and CD4/CD8 ratio in HIV-infected patients switching to a dual therapy with lamivudine plus boosted darunavir

J. Casado, M. Vivancos, A. Moreno, 2019, Infectious diseases.

Validation of a Specific Questionnaire on Psychological and Social Repercussions of the Lipodystrophy Syndrome in HIV-infected Patients

S. Moreno, A. Antela, J. Casado, 2006, Quality of Life Research.

Dynamics of the HIV-1 latent reservoir after discontinuation of the intensification of antiretroviral treatment: results of two clinical trials

J. Zamora, M. Muñoz-Fernández, B. Hernández-Novoa, 2013, AIDS.

High virological failure rate in HIV patients after switching to a regimen with two nucleoside reverse transcriptase inhibitors plus tenofovir

V. Abraira, S. Moreno, M. Pérez-Elías, 2005, AIDS.

Raltegravir plus Two Nucleoside Analogues as Combination Antiretroviral Therapy in HIV-Infected Patients who Require Cancer Chemotherapy

J. Moltó, J. Casado, A. Moreno, 2015, Antiviral therapy.

Central nervous system antiretroviral penetration and cognitive functioning in largely pretreated HIV-infected patients

S. Moreno, M. Pérez-Elías, J. Casado, 2014, Journal of NeuroVirology.

Changes in Kidney Function and in the Rate of Tubular Dysfunction After Tenofovir Withdrawal or Continuation in HIV-Infected Patients

F. Liaño, S. Moreno, M. Pérez-Elías, 2016, Journal of acquired immune deficiency syndromes.

Outcomes by sex following treatment initiation with darunavir/cobicistat in a large Spanish cohort of the CODAR study (GeSIDA 9316).

J. M. García de Lomas, J. De La Torre, E. Ribera, 2019, The Journal of antimicrobial chemotherapy.

“Real Life” Safety and Efficacy of IFN/RBV-Free, Full-Dose SOF-Based Therapy in Kidney Transplanted Patients

C. Quereda, F. Liaño, S. Moreno, 2016 .

“Real Life” Data on Daas Use among HCV-Patients with Moderate to Severe Chronic Kidney Disease not on Hemodialysis

C. Quereda, S. Moreno, M. Pérez-Elías, 2016 .

Pegylated interferon alpha2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected patients.

C. Quereda, S. Moreno, M. Pérez-Elías, 2004, AIDS.

Effect of Treatment With Efavirenz on Neuropsychiatric Adverse Events of Interferon in HIV/HCV-Coinfected Patients

C. Quereda, S. Moreno, M. Pérez-Elías, 2008, Journal of acquired immune deficiency syndromes.

Implementation of a lung cancer screening initiative in HIV-infected subjects

S. Moreno, M. Pérez-Elías, L. Gorospe, 2021, PloS one.

High CD8 T cell percentage and HCV replication control are common features in HIV-1 controllers and HTLV-2-co-infected patients with a history of injection drug use.

E. Ruiz-Mateos, M. Leal, L. Tarancón-Díez, 2019, Virus research.

Social isolation in HIV-infected patients according to subjective patient assessment and DEXA-confirmed severity of lipodystrophy

S. Moreno, M. Pérez-Elías, J. Casado, 2013, AIDS care.

Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1.

S. Moreno, M. Pérez-Elías, A. Antela, 2003, AIDS.

Severity of the Toxicity Associated With Combinations That Include Didanosine Plus Stavudine in HIV-Infected Experienced Patients

S. Moreno, M. Pérez-Elías, A. Antela, 2006, Journal of Acquired Immune Deficiency Syndromes.

A Clinical Study of the Combination of 100 mg Ritonavir plus 800 mg Indinavir as Salvage Therapy: Influence of Increased Plasma Drug Levels in the Rate of Response

S. Moreno, M. Pérez-Elías, A. Antela, 2000, HIV clinical trials.

Treatment of hepatitis C virus with direct-acting antivirals: Practical aspects and current situation

C. Quereda, M. Vivancos, A. Moreno, 2018 .

Candidal meningitis in HIV-infected patients: analysis of 14 cases.

C. Quereda, E. Navas, J. Casado, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Prevalence of causes of secondary osteoporosis and contribution to lower bone mineral density in HIV-infected patients

S. Moreno, J. Casado, A. Moreno, 2014, Osteoporosis International.

[HIV infection in immigrants in Spain: Epidemiological characteristics and clinical presentation in the CoRIS Cohort (2004-2006)].

C. Tural, J. Miro, M. Salavert, 2009, Enfermedades Infecciosas y Microbiologia Clinica.

Regression of liver fibrosis is progressive after sustained virological response to HCV therapy in patients with hepatitis C and HIV coinfection

C. Quereda, S. Moreno, M. Pérez-Elías, 2013, Journal of viral hepatitis.

Semiquantitative culture of subcutaneous segment for conservative diagnosis of intravascular catheter-related infection.

Á. Asensio, A. Guerrero, J. Pérez-Molina, 2000, JPEN. Journal of parenteral and enteral nutrition.

Expanding HIV clinical monitoring: the role of CD4, CD8, and CD4/CD8 ratio in predicting non-AIDS events

Miguel Ángel Martínez, B. Rodés, E. Poveda, 2023, EBioMedicine.

A Risk Assessment Tool for Predicting Fragility Fractures in People with HIV: Derivation and Internal Validation of the FRESIA Model

A. Curran, J. Casado, P. Vizcarra, 2023, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co‐infection

C. Tural, J. del Romero, J. Pineda, 2009, Journal of viral hepatitis.

Severe sirolimus-related inflammatory state anemia in an HIV+ liver transplant patient with calcineurin inhibitor renal insufficiency: a case report.

C. Quereda, J. Fortún, A. Moreno, 2008, Transplantation proceedings.

Limitations of a Simplification Antiretroviral Strategy for HIV-Infected Patients with Decreasing Adherence to a Protease Inhibitor Regimen

S. Moreno, M. Pérez-Elías, A. Antela, 2006, HIV clinical trials.